Compare ABR & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABR | RAPP |
|---|---|---|
| Founded | 2003 | 2022 |
| Country | United States | United States |
| Employees | 653 | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2024 |
| Metric | ABR | RAPP |
|---|---|---|
| Price | $5.93 | $38.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $9.90 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 4.0M | 356.3K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | ★ 15.42% | N/A |
| EPS Growth | N/A | ★ 24.34 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.69 | $7.73 |
| 52 Week High | $12.58 | $42.27 |
| Indicator | ABR | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 25.14 | 59.14 |
| Support Level | N/A | $25.48 |
| Resistance Level | $8.15 | $41.59 |
| Average True Range (ATR) | 0.33 | 2.30 |
| MACD | -0.25 | 0.07 |
| Stochastic Oscillator | 7.89 | 68.65 |
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.